What is Labcorp Holdings's market cap?

Labcorp Holdings (LH) has a market capitalization of $22.8B and trades on NYSE.

What is Labcorp Holdings's revenue and profitability?

Labcorp Holdings generated $14.1B in trailing twelve-month revenue with net income of $941.5M, representing a net margin of 6.7%. Gross margin stands at 28.8%, with free cash flow of $1.4B. These figures are based on the Q1 2026 filing.

Who are Labcorp Holdings's competitors?

Labcorp Holdings's key competitors include Quest Diagnostics, Charles River Laboratories, IQVIA, and others. These companies compete in similar markets and product categories.

Who does Labcorp Holdings partner with?

Labcorp Holdings's notable partners include Project HOPE, American Red Cross.

Where is Labcorp Holdings headquartered?

Labcorp Holdings is headquartered in United States of America and employs approximately 67,000 people. It has been publicly traded since 1988.

Labcorp Holdings

Labcorp is a global life sciences company that provides comprehensive laboratory services to support clinical decision-making and drug development.

Market cap

$22.77B+3.9%

Revenue$14.1B+7.3%

Net income$941.5M+28.8%

Free cash flow$1.4B+20.1%

EPS (diluted)$11.29+30.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 30, 2026

Revenue$3.5BBeat by $28.8M EPS$4.25Beat by $0.16

Read the full report

Next report

Jul 30, 2026 (In 2 weeks)

Revenue estimate$3.7B

EPS estimate$4.79

Financials

Q1 2026

Income statement

See full

Revenue$3.5B+5.8%

Gross profit$1.0B+6.9%

Operating income$380.8M+16.8%

Net income$277.8M+30.5%

EPS (diluted)$3.35+32.9%

Balance sheet

See full

Cash & equivalents$981.1M+166%

Total debt$7.2B+11.1%

Total equity$8.7B+5.1%

Total assets$19.1B+8.4%

Cash flow

See full

Operating cash flow$191.5M+935%

CapEx$121.0M-4.0%

Free cash flow$70.5M+166%

Valuation & ratios

Valuation

See full

Market cap$22.77B+3.9%

Enterprise value$29.03B+6.3%

P/E24.2×-4.5×

P/S1.6×0.0×

Profitability

See full

Gross margin28.8%+0.9pp

Operating margin10.2%+1.9pp

Net margin6.7%+1.1pp

FCF margin9.8%+1.0pp

Returns & leverage

See full

Return on equity11.1%+2.1pp

Debt / equity0.8×0.0×

Current ratio1.7×-0.1×

Segments

By segment

See full

Diagnostics$2.8B+5.0%

Biopharma Laboratory Services$780.6M+8.2%

Competitors

By market cap

IQVIA$34.0B+19.7%

Quest Diagnostics$23.0B+16.7%

Labcorp Holdings$22.8B+3.9%

Icon$12.7B+6.2%

Charles River Laboratories$10.8B+39.8%

Bio-Rad Laboratories$7.6B+11.0%

Personalis, Inc.$1.5B+125%

Quanterix Corporation$182.3M-32.8%

By revenue growth

Quest Diagnostics+11.0%

Labcorp Holdings+7.3%

IQVIA+7.3%

Quanterix Corporation+6.9%

Bio-Rad Laboratories+1.9%

Charles River Laboratories+0.1%

Personalis, Inc.-24.7%

By net margin

Quest Diagnostics9.08%+0.2pp

IQVIA8.33%-0.3pp

Labcorp Holdings6.66%+1.1pp

Bio-Rad Laboratories6.52%+91.7pp

Charles River Laboratories-4.59%-11.1pp

Quanterix Corporation-71.86%-36.6pp

Personalis, Inc.-148.11%-50.0pp

Profile

Labcorp is a global life sciences company that provides comprehensive laboratory services to support clinical decision-making and drug development. The company operates an extensive diagnostic network and provides critical support for the majority of new FDA-approved drugs through its research and clinical trial capabilities. Its value proposition centers on integrating large-scale diagnostic data with drug development insights to improve patient outcomes and accelerate medical innovation.

Competitive position

A leading global provider of laboratory services with a dominant position in the U.S. clinical testing market and a significant role in supporting global drug development.

GeographiesUnited States, Canada, Europe, Asia

Customer segmentsHealthcare Providers, Biopharmaceutical Companies, Government Agencies, Individual Consumers

Business modelFee-for-service, Capitation, B2B Service, Direct-to-Consumer

SuppliersLaboratory equipment manufacturers, Chemical and reagent suppliers, IT and cloud infrastructure providers, Logistics and transportation services

CustomersHospitals and health systems, Biopharmaceutical R&D departments, Health insurance payers, Retail healthcare consumers

CountryUnited States of America

Listed1988

Employees67.0K

CEOAdam H. Schechter

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websitelabcorp.com

FilingsSEC EDGAR

Ask your AI about Labcorp Holdings.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Labcorp Holdings's market cap?: Labcorp Holdings (LH) has a market capitalization of $22.8B and trades on NYSE.
What is Labcorp Holdings's revenue and profitability?: Labcorp Holdings generated $14.1B in trailing twelve-month revenue with net income of $941.5M, representing a net margin of 6.7%. Gross margin stands at 28.8%, with free cash flow of $1.4B. These figures are based on the Q1 2026 filing.
Who are Labcorp Holdings's competitors?: Labcorp Holdings's key competitors include Quest Diagnostics, Charles River Laboratories, IQVIA, and others. These companies compete in similar markets and product categories.
Who does Labcorp Holdings partner with?: Labcorp Holdings's notable partners include Project HOPE, American Red Cross.
Where is Labcorp Holdings headquartered?: Labcorp Holdings is headquartered in United States of America and employs approximately 67,000 people. It has been publicly traded since 1988.